• Nicole L Nichols, Genevieve Gowing, Irawan Satriotomo, Lisa J Nashold, Erica A Dale, Masatoshi Suzuki, Pablo Avalos, Patrick L Mulcrone, Jacalyn McHugh, Clive N Svendsen, and Gordon S Mitchell.
• Department of Comparative Biosciences, University of Wisconsin, Madison, WI 53706, USA.
• Am. J. Respir. Crit. Care Med. 2013 Mar 1; 187 (5): 535-42.

RationaleAmyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease causing paralysis and death from respiratory failure. Strategies to preserve and/or restore respiratory function are critical for successful treatment. Although breathing capacity is maintained until late in disease progression in rodent models of familial ALS (SOD1(G93A) rats and mice), reduced numbers of phrenic motor neurons and decreased phrenic nerve activity are observed. Decreased phrenic motor output suggests imminent respiratory failure.ObjectivesTo preserve or restore phrenic nerve activity in SOD1(G93A) rats at disease end stage.MethodsSOD1(G93A) rats were injected with human neural progenitor cells (hNPCs) bracketing the phrenic motor nucleus before disease onset, or exposed to acute intermittent hypoxia (AIH) at disease end stage.Measurements And Main ResultsThe capacity to generate phrenic motor output in anesthetized rats at disease end stage was: (1) transiently restored by a single presentation of AIH; and (2) preserved ipsilateral to hNPC transplants made before disease onset. hNPC transplants improved ipsilateral phrenic motor neuron survival.ConclusionsAIH-induced respiratory plasticity and stem cell therapy have complementary translational potential to treat breathing deficits in patients with ALS.

24 keywords...

hide…